FMR LLC

Position in GMAB — Genmab A/S

CIK 315066 BOSTON, MA

Back to GMAB Full portfolio

Position in GMAB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,144,607

-$5,421,463 QoQ

Shares Held

1,011,726

-4.3% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 17.246171394231244.ToString("F0")% Shared 0.ToString("F0")% None 82.75382860576876.ToString("F0")%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. GMAB ranks #118 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

All Filings in GMAB

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,144,607	1,011,726	-4.3%	Shares	Defined	2026-05-15
2025-12-31	$32,566,070	1,057,340	-5.6%	Shares	Defined	2026-02-17
2025-09-30	$34,341,627	1,119,714	+64.5%	Shares	Defined	2025-11-13
2025-06-30	$14,059,811	680,533	+40.4%	Shares	Defined	2025-08-14
2025-03-31	$9,493,284	484,846	-10.3%	Shares	Defined	2025-05-12
2024-12-31	$11,281,339	540,553	+94.3%	Shares	Defined	2025-02-13
2024-09-30	$6,782,368	278,194	+13.5%	Shares	Defined	2024-11-13
2024-06-30	$6,159,813	245,118	-34.5%	Shares	Defined	2024-08-13
2024-03-31	$11,198,512	374,407	+40.0%	Shares	Defined	2024-05-13
2023-12-31	$8,517,357	267,505	-36.7%	Shares	Defined	2024-02-13
2023-09-30	$14,899,351	422,437	+6.3%	Shares	Defined	2023-11-13
2023-06-30	$15,109,011	397,501	+1.6%	Shares	Defined	2023-08-11
2023-03-31	$14,779,678	391,411	-13.3%	Shares	Defined	2023-08-11
2022-12-31	$19,141,306	451,659	+3.4%	Shares	Defined	2023-02-13
2022-09-30	$14,040,744	436,998	+77.7%	Shares	Defined	2022-11-10
2022-06-30	$7,990,167	245,927	+11.5%	Shares	Defined	2022-08-12
2022-03-31	$7,981,560	220,607	+43.9%	Shares	Defined	2022-05-13
2021-12-31	$6,066,485	153,349	+16.3%	Shares	Defined	2022-02-14
2021-09-30	$5,763,591	131,890	+17.1%	Shares	Defined	2022-02-14
2021-06-30	$4,597,049	112,590	-34.7%	Shares	Defined	2021-08-13
2021-03-31	$5,659,957	172,402	+106.5%	Shares	Defined	2021-05-14
2020-12-31	$3,393,808	83,468	-67.0%	Shares	Defined	2021-02-08
2020-09-30	$9,252,188	252,723	+1367.6%	Shares	Defined	2020-11-13
2020-06-30	$583,585	17,220	+99.5%	Shares	Defined	2020-08-24
2020-03-31	$182,890	8,631	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.